Apr 1, 2025 8:30am EDT MAIA Biotechnology CEO Details Anticipated Clinical Milestones for Novel Cancer Immunotherapy in 2025 Letter to Shareholders
Mar 25, 2025 8:46am EDT MAIA Biotechnology Announces Poster Presentation at ESMO's European Lung Cancer Congress 2025
